Ampio sued by shareholder over allegedly false statements made about osteoarthritis drugs

Published



LOS ANGELES (Legal Newsline) – A biopharmaceutical company is being sued by a stockholder for conducting a clinical research study that allegedly lacked independence.

Shiva Stein filed the lawsuit on May 14 in U.S. District Court of California against Ampio Pharmaceuticals and its executives claiming the company also shipped drugs to the study at lower temperatures than permitted.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.